Although the origin of FGL2 in glioma is not fully understood, it has been shown to be expressed mainly in immune cells such as endothelial cells, macrophages, NK cells, T cells and tumor cells (27, 37). This evidence concerns the gene FGL2 and central nervous system cancer.